Literature DB >> 5423298

The intercurrent hypertension of primary aldosteronism.

E G Biglieri, M Schambelan, P E Slaton, J R Stockigt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5423298

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  13 in total

1.  [Haemodynamic studies on the blood pressure-raising effect of mineralocorticoids (author's transl)].

Authors:  A Distler; T Philipp
Journal:  Klin Wochenschr       Date:  1979-11-02

Review 2.  MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

3.  Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.

Authors:  F Fallo; N Sonino; M Boscaro; D Armanini; F Mantero; H G Dörr; D Knorr; U Kuhnle
Journal:  Klin Wochenschr       Date:  1987-05-15

4.  Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.

Authors:  David C Kem; Hongliang Li; Carolina Velarde-Miranda; Campbell Liles; Megan Vanderlinde-Wood; Allison Galloway; Muneer Khan; Caitlin Zillner; Alexandria Benbrook; Veitla Rao; Celso E Gomez-Sanchez; Madeleine W Cunningham; Xichun Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

5.  Primary aldosteronism and malignant adrenocortical neoplasia.

Authors:  T M Salassa; R E Weeks; R C Northcutt; J A Carney
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

6.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 7.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

8.  Evolution of the surgical management of primary aldosteronism.

Authors:  S P Auda; M F Brennan; J R Gill
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

9.  Selection of patients and operative approach in primary aldosteronism.

Authors:  T K Hunt; M Schambelan; E G Biglieri
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

10.  Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

Authors:  J J Brown; D L Davies; J B Ferriss; R Fraser; E Haywood; A F Lever; J I Robertson
Journal:  Br Med J       Date:  1972-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.